$806 Million is the total value of Foyston, Gordon, & Payne Inc's 89 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KO | Coca Cola Co. | $3,872,000 | +9.1% | 93,720 | 0.0% | 0.48% | +3.9% | |
| MDLZ | Mondelez International Inc. | $1,951,000 | +12.4% | 55,256 | 0.0% | 0.24% | +6.6% | |
| BRKB | Berkshire Hathaway Inc. CL B | $1,935,000 | +4.4% | 16,323 | 0.0% | 0.24% | -0.8% | |
| WMT | Wal-Mart Stores Inc. | $1,570,000 | +6.4% | 19,950 | 0.0% | 0.20% | +1.0% | |
| XOM | Exxon Mobil Corp. | $1,126,000 | +17.5% | 11,131 | 0.0% | 0.14% | +12.0% | |
| KRFT | Kraft Foods Group Inc. | $993,000 | +2.8% | 18,418 | 0.0% | 0.12% | -2.4% | |
| MMM | 3M Co. | $901,000 | +17.5% | 6,424 | 0.0% | 0.11% | +12.0% | |
| PG | Procter & Gamble Co. | $860,000 | +7.8% | 10,563 | 0.0% | 0.11% | +2.9% | |
| NVS | Novartis AG - ADR | $693,000 | +4.8% | 8,619 | 0.0% | 0.09% | 0.0% | |
| BDX | Becton Dickinson & Co. | $696,000 | +10.5% | 6,300 | 0.0% | 0.09% | +4.9% | |
| ABBV | AbbVie Inc. | $664,000 | +18.1% | 12,570 | 0.0% | 0.08% | +12.3% | |
| IBM | IBM | $586,000 | +1.2% | 3,126 | 0.0% | 0.07% | -3.9% | |
| UTX | United Technologies Corp. | $590,000 | +5.5% | 5,185 | 0.0% | 0.07% | 0.0% | |
| IVV | IShares S&P 500 Index Fund | $576,000 | +9.9% | 3,100 | 0.0% | 0.07% | +4.4% | |
| ABT | Abbott Laboratories | $482,000 | +15.6% | 12,570 | 0.0% | 0.06% | +11.1% | |
| USB | U.S. Bancorp. | $386,000 | +10.6% | 9,553 | 0.0% | 0.05% | +4.3% | |
| WFC | Wells Fargo Co. | $337,000 | +9.8% | 7,421 | 0.0% | 0.04% | +5.0% | |
| ACETQ | Aceto Corp. | $296,000 | +60.0% | 11,851 | 0.0% | 0.04% | +54.2% | |
| JPM | JPMorgan Chase & Co. | $261,000 | +13.0% | 4,471 | 0.0% | 0.03% | +6.7% | |
| PFE | Pfizer Inc. | $214,000 | +6.5% | 6,993 | 0.0% | 0.03% | +3.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-02-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft Corp. | 42 | Q3 2023 | 10.2% |
| Johnson & Johnson | 42 | Q3 2023 | 9.3% |
| Mondelez International Inc. | 42 | Q3 2023 | 4.0% |
| Coca Cola Co. | 42 | Q3 2023 | 1.7% |
| Berkshire Hathaway Inc. CL B | 42 | Q3 2023 | 1.6% |
| Becton Dickinson & Co. | 42 | Q3 2023 | 2.7% |
| Wal-Mart Stores Inc. | 42 | Q3 2023 | 0.9% |
| AbbVie Inc. | 42 | Q3 2023 | 0.5% |
| Abbott Laboratories | 42 | Q3 2023 | 0.4% |
| Procter & Gamble Co. | 42 | Q3 2023 | 0.2% |
View Foyston, Gordon, & Payne Inc's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Foyston, Gordon, & Payne Inc | September 20, 2012 | 4,798,387 | 4.8% |
| Foyston, Gordon, & Payne Inc | April 25, 2012 | 8,966,382 | 9.2% |
| TECUMSEH PRODUCTS CO | July 17, 2006 | 553,579 | 4.1% |
| CPI CORPSold out | April 27, 2006 | 0 | 0.0% |
View Foyston, Gordon, & Payne Inc's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-07 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-10-26 |
| 13F-HR | 2023-08-01 |
| 13F-HR | 2023-05-03 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-04 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-04-27 |
| 13F-HR | 2022-02-11 |
View Foyston, Gordon, & Payne Inc's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.